Artemis Medicare

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE025R01021
  • NSEID: ARTEMISMED
  • BSEID: 542919
INR
219.05
-20.35 (-8.5%)
BSENSE

Feb 03

BSE+NSE Vol: 8.55 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
802.01
697.02
653.33
542.14
405.37
279.25
426.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
802.01
697.02
653.33
542.14
405.37
279.25
426.55
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
79.08
104.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.10
0.23
1.14
(Increase) / Decrease In Stocks
0.00
0.01
0.00
0.00
0.09
1.08
-1.03
Employee Cost
121.10
109.23
102.88
89.35
75.40
62.10
76.99
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
488.85
419.29
406.20
339.74
248.33
-0.02
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
55.49
52.60
49.50
44.76
31.05
121.81
196.60
Total Expenditure (Excl Depreciation)
665.44
581.13
558.58
473.85
354.97
264.28
378.04
Operating Profit (PBDIT) excl Other Income
136.57
115.89
94.75
68.29
50.40
14.97
48.51
Other Income
22.04
20.64
5.45
4.96
2.66
2.14
2.55
Operating Profit (PBDIT)
158.61
136.53
100.20
73.25
53.06
17.11
51.06
Interest
21.32
24.11
22.72
14.41
8.27
10.33
9.84
Exceptional Items
-3.07
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
134.22
112.42
77.48
58.84
44.79
6.78
41.22
Depreciation
35.31
33.42
29.28
22.27
15.80
16.40
16.90
Profit Before Tax
98.93
79.00
48.22
36.57
28.99
-9.64
24.30
Tax
25.49
19.75
13.38
9.26
10.79
-3.15
9.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
73.43
59.26
34.84
27.31
18.19
-6.49
15.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
73.43
59.26
34.84
27.31
18.19
-6.49
15.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.06
0.20
0.12
0.33
0.11
0.11
0.18
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
73.59
59.60
34.96
28.00
18.56
-6.21
15.48
Equity Capital
15.83
13.76
13.59
13.41
13.24
13.24
13.24
Face Value
1.0
1.0
1.0
1.0
1.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
1.41
1.31
0.83
0.75
0.47
4.03
4.25
Operating Profit Margin (Excl OI)
17.03%
16.63%
14.5%
12.6%
12.43%
5.36%
11.37%
Gross Profit Margin
16.74%
16.13%
11.86%
10.85%
11.05%
2.43%
9.66%
PAT Margin
9.16%
8.5%
5.33%
5.04%
4.49%
-2.32%
3.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 15.06% vs 6.69% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 23.47% vs 70.48% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 17.84% vs 22.31% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -11.57% vs 6.12% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Artemis Medicare With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
802.01
0
802.01
Other Operating Income
0.00
0.00
0.00
Total Operating income
802.01
0
802.01
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.00
0
0.00
Employee Cost
121.10
0
121.10
Power Cost
0.00
0
0.00
Manufacturing Expenses
488.85
0
488.85
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
55.49
0.00
55.49
Total Expenditure (Excl Depreciation)
665.44
0
665.44
Operating Profit (PBDIT) excl Other Income
136.57
0.00
136.57
Other Income
22.04
0
22.04
Operating Profit (PBDIT)
158.61
0
158.61
Interest
21.32
0
21.32
Exceptional Items
-3.07
0
-3.07
Gross Profit (PBDT)
134.22
0
134.22
Depreciation
35.31
0
35.31
Profit Before Tax
98.93
0
98.93
Tax
25.49
0
25.49
Provisions and contingencies
0.00
0
0.00
Profit After Tax
73.43
0
73.43
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
73.43
0
73.43
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.06
0
-0.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
73.59
0
73.59
Equity Capital
15.83
0
15.83
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
16.74%
0%
0.00
16.74%
PAT Margin
9.16%
0%
0.00
9.16%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 802.01 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 15.06% vs 6.69% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 73.59 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 23.47% vs 70.48% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 136.57 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 17.84% vs 22.31% in Dec 2024

Nine Monthly - Interest
Interest 21.32 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -11.57% vs 6.12% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.03%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024